1. A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma. Issue 9 (16th May 2019) Authors: Pak, Ekaterina; MacKenzie, Ethan L; Zhao, Xuesong; Pazyra-Murphy, Maria F; Park, Paul M C; Wu, Lei; Shaw, Daniel L; Addleson, Emily C; Cayer, Suzanne S; Lopez, Begoña G-C; Agar, Nathalie Y R; Rubin, Lee L; Qi, Jun; Merk, Daniel J; Segal, Rosalind A Journal: Neuro-oncology Issue: Volume 21:Issue 9(2019) Page Start: 1150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗